MIB1 proliferation index in meningiomas: Does it predict recurrence? A clinicopathological study

British Journal of Neurosurgery

Volumn 18, Issue 4, 2004, Pages 357-361

  Tyagi, A ^a   Chakrabarty, A ^a   Franks, A ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Histology; Meningioma; Proliferation index; Recurrence; Surgical resection

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MENINGIOMA; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK;

ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; COMBINED MODALITY THERAPY; HUMANS; KI-67 ANTIGEN; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS;

EID: 9644296027     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688690400005008     Document Type: Article

References (40)

1. May P, Broome J, Lawry J, Buxton RA, Battersby RDE. The prediction of recurrence in meningiomas. A flow cytometric study of paraffin embedded archival material. J Neurosurg 1989;71:347-51.
2. Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, et al. Meningiomas: clinical implications of a high proliferative potential determined by Bromodeoxyuridine labelling. Neurosurgery 1992;30:494-8.
3. Kiss R, Dewitte O, Decaestecker C, Camby I, Gordower L, Delbecque K, et al. The combined determination of the proliferation and cell density in the prognosis of adult patients with supratentorial High Grade astrocytic tumors. Am J Clin Pathol 1997;107:321-31.
4. Cobb M, Hussain M, Andersen B, Al-Mefty O. Significance of proliferation nuclear antigen in predicting recurrence of intracranial meningiomas. J Neurosurg 1996;84:85-90.
5. Adegbite A, Khan M, Paine K, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983;58:51-6.
6. Ironside J, Battersby R, Lawry J, Loomes RS, Day CA, Timperley WR. DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates. J Neurosurg 1987;66:588-94.
7. Fromm H, Schafer M, Vitzthum H. Clinical course of intracranial meningiomas with respect to their histological stage. Acta Neurochir (Wien) 1995;31:277(Abstract).
8. Hsu D, Efird J, Hedley Whyte E. Progesterone and estrogen receptors in meningiomas, prognostic considerations. J Neurosurg 1997;86:113-20.
9. Hoshino T, Nagashima T, Murovic J, Wilson CB, Davis RL. Proliferative potential of human meningiomas of the brain. A cell kinetic study with bromodeoxyuridine. Cancer 1986;58:1466-72.
10. Hsu D, Pardo F, Efird J, Linggood RM, Hedley-Whyte T. Prognostic significance of proliferative indices in meningioma. J Neuropathol Exp Neurol 1994;53:247-55.
11. Mirimanoff R, Dosoretz D, Linggood R, Ojemann R, Martuza R. Meningioma analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18-24.
12. Hoshino T, Wilson C. Cell kinetic analysis of human malignant brain tumors. Cancer 1979;44:956-62.
13. Kunishio K, Ohmoto T, Matsuhisa T, Maeshiro T, Furuta T, Matsumoto K. The significance of Nucleolar Organiser region (AgNOR) score in predicting meningioma recurrence. Cancer 1994;73:2200-5.
14. Burger P, Shibata T, Kleihues P. The use of the monoclonal antibody Ki67 in the identification of proliferating cells. Application to surgical neuropathology. Am J Surg Pathol 1986;10:611-17.
15. Giangaspero F, Doglioni C, Rivano M, Piled S, Gerdes J, Stein H. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 1987;74:179-82.
16. Montine T, Van der Steen Oven J, Aguzzi A, Boyko OB, Dodge RK, Kerns BJ, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary Astrocytic neoplasm. Neurosurgery 1994;34:674-9.
17. Cattoretti G, Becker M, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki 67 antigen (MIB-1 and MIB-3) detect proliferating cells in the microwave processed formalin fixed paraffin sections. J Pathol 1992;168:357-63.
18. Key G, Becker M, Baron B, Duchrow M, Schluter C, Flad HD, et al. New Ki 67 equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki 67 c DNA containing three 62 base pair repetitive elements encoding for the Ki 67 epitope. Lab Invest 1993;68:629-36.
19. Onda K, Davis R, Shibuya M, Wilson CB, Hoshino T. Correlation between the Bromodeoxyuridine labelling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-6.
20. Langford L, Looksley L, Demonte F. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 1996;27:350-4.
21. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M. MIB-1 staining and scoring of histological features in meningioma. Indications for the prediction of biologic potential and post-operative management. Cancer 1994;74:3176-89.
22. Coons SW, Johnson PC, Pearl DK. The prognostic significance of Ki67 labelling indices for oligodendrogliomas. Neurosurgery 1997;41:878-85.
23. Jaros E, Perry R, Adam L, Kelly PJ, Crawford PJ, Kalbag PM, et al. Prognostic implication of p53 protein, epidermal growth factor receptor and Ki 67 labelling in Brain tumors. Br J Cancer 1992;66:373-85.
24. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D. Relationship between Ki-67 positive cells and growth rate and histological type of human intracranial tumors. Anticancer Res 1988;8:537-44.
25. Hsu D, Efird J, Hedley-White E. MIB 1 (Ki 67) index and transforming growth factor alpha(TGF α) immunereactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 1998;24:441-52.
26. Karamitopoulou E, Perentes E, Tolnay M, Probst A. Prognostic significance of MIB-1, p-53 and bcl-2: immunoreactivity in meningiomas. Hum Pathol 1998;29:140-5.
27. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, et al. Clinical and histopathological analysis of proliferative potential of recurrent and non recurrent meningiomas. Acta Neuropathol (Berl) 1996;91:504-10.
28. Prayson R. Malignant meningiomas. A clinicopathologic study of 23 patients including MIB-1 and p53 immunoreactivity. Am J Clin Pathol 1996;105.
29. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39.
30. Kleihues P, Cavenee WK. Pathology and genetics. Tumours of nervous system, in Kleihues P, Cavenee WK, eds, World Health Organisation classification of tumours. Lyon: IARC Press, 2000.
31. Alvarez F, Roda J, Romero M, Morales C, Sarmiento MA, Blazquez MG. Malignant and atypical meningiomas: a reappraisal of clinical, histological and CT features. Neurosurgery 1987;20:688-94.
32. Beks J, de Windt H. The recurrence of supratentorial meningiomas after surgery. Acta Neurochir (Wien) 1988;95:3-5.
33. Cromptons M, Gautier Smith P. The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiat 1970;33:80-6.
34. De la Monte S, Flickinger J, Linggood R. Histopathologic features predicting recurrence in meningiomas following subtotal resection. Am J Surg Path 1986;10:836-43.
35. Dietemann J, Heldt N, Burguet J, Medjek L, Maitrot D, Wackenheim A. CT findings in malignant meningiomas. Neuroradiology 1982;23:207-9.
36. Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma. Late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986;26:461-9.
37. Kepes J. Presidential address: the histopathology of meningiomas. A reflection of origins and expected behaviour. J Neuropathol Exp Neurol 1986;45:95-107.
38. Christensen D, Laursen H, Klinken L. Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol 1983;61:130-4.
39. Jellinger K, Slowik F. Histological subtypes and prognostic problems in meningiomas. J Neurol 1975;208:279-98.
40. Adam I, Mohamdee M, Martin I, Scott N, Finan PJ, Johnston D, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.